A Study Of Frontier X Plus Chest-strap ECG Monitor

Overview

About this study

The purpose of this study is to evaluate the feasibility, usability, and comfort of the Frontier X Plus chest-strap ECG device in active individuals and to explore physician confidence in interpreting selected ECG segments recorded during daily activity and exercise.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  •  Adult participants (>22 years; Frontier X is approved for use in this age group) who participate in >4 days a week of >150 minutes total per week of moderate to high intensity exercise who were prescribed a 7-14 day ambulatory ECG monitor for clinical purposes.

  • Patients must agree to wear the Frontier X monitor for the prescribed duration and use the Frontier X Plus application

Exclusion Criteria:

  • Current use of Implanted Cardiac Devices

  • Pregnancy

  • Known allergies to any of the materials listed in the “List of Patient-Contacting Materials”

  • Presence of skin injuries or broken skin in the area where the chest strap is worn

  • Inability to use a compatible mobile device required for the operation of the study device

  • Any cognitive or physical limitations that, in the opinion of the investigator, limits the participant’s ability to fully follow study procedures

  • Medical restrictions on exercise for safety including cardiac, orthopedic or other relevant past medical history

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 11/05/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Darrell Newman, M.D.

Contact us for the latest status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Regis Fernandes, M.D.

Contact us for the latest status

Jacksonville, Fla.

Mayo Clinic principal investigator

Elizabeth Dineen, D.O.

Contact us for the latest status

Contact information:

Elizabeth Dineen

9049530859

dineen.elizabeth@mayo.edu

More information

Publications

Publications are currently not available